Documents Neil Shah_Optimal Management of CML in 2015_part 3

Evolving CML Treatment Landscape Evolving CML Treatment Landscape GLEEVEC® (imatinib) approved by FDA1 TASIGNA® (nilotinib) for resistant or intolerant CP Ph+ CML approved…